You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 301 No. 22, June 10, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •HIV/AIDS
 •Public Health, Other
 •Screening
 •Drug Therapy
 •Drug Therapy, Other
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Universal Voluntary Testing and Treatment for Prevention of HIV Transmission

Carl W. Dieffenbach, PhD; Anthony S. Fauci, MD

JAMA. 2009;301(22):2380-2382.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Antiretroviral therapy (ART) can suppress the level of human immunodeficiency virus (HIV) viremia (or "viral load") to undetectable levels in the plasma of a substantial proportion of individuals infected with HIV and has greatly reduced HIV-related morbidity and mortality.1 In addition, the efficiency of HIV transmission is directly proportional to the viral load in the transmitting individual.2 Given the dramatic effect of ART on viral load, it is reasonable to consider using treatment of individuals infected with HIV as a means of preventing HIV transmission. The notion of treating individuals who are infected in the general population as a means of controlling the HIV/AIDS pandemic by decreasing the rate of HIV transmission—and thus lessening the societal spread of HIV—is not new.3

A recent modeling study by Granich et al4 reaches provocative conclusions and provides the theoretical basis for a new and potentially . . . [Full Text of this Article]

Universal Testing

Author Affiliations: National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTERS

Strategies for Preventing HIV Transmission
David R. Holtgrave
JAMA. 2009;302(14):1530-1531.
EXTRACT | FULL TEXT  

Strategies for Preventing HIV Transmission
Seth Kalichman and Lisa Eaton
JAMA. 2009;302(14):1531.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Investing To Meet The Scientific Challenges Of HIV/AIDS
Fauci and Folkers
Health Aff (Millwood) 2009;28:1629-1641.
ABSTRACT | FULL TEXT  

Strategies for Preventing HIV Transmission
Holtgrave
JAMA 2009;302:1530-1531.
FULL TEXT  

Strategies for Preventing HIV Transmission
Kalichman and Eaton
JAMA 2009;302:1531-1531.
FULL TEXT  

HIV transmission risk behaviours among HIV seropositive sexually transmitted infection clinic patients in Cape Town, South Africa
Kalichman et al.
Eur J Public Health 2009;0:ckp127v1-ckp127.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.